May 20, 2013 09:15AM Neuralstem ALS Trial Principal Investigator, Dr. Eva Feldman, Presented Phase I Data At The Neuro Diabetes Medical Symposium In Romania
May 16, 2013 09:15AM Neuralstem CEO, Richard Garr, To Present At Annual World Stem Cells And Regenerative Medicine Congress In London
May 13, 2013 09:15AM Neuralstem Principal Investigator, Dr. Eva Feldman, Presents Phase I ALS Trial Data At The Romanian Neurological Society Congress
May 10, 2013 04:24PM Neuralstem Reports First Quarter Financial Results And Provides Business And Clinical Update
May 8, 2013 09:15AM Neuralstem ALS Trial Investigator And Patient On Sirius XM
Apr 29, 2013 11:15AM Neuralstem ALS Trial Data Presented At The American Association Of Neurological Surgeons Annual Meeting
Apr 24, 2013 09:15AM Neuralstem And The National Football League Alumni Association Announce Initiative On Brain Injury Treatment
Apr 22, 2013 09:15AM FDA Approves Neuralstem To Treat Final Cohort In NSI-189 Phase Ib Trial In Major Depressive Disorder
Apr 18, 2013 09:15AM Neuralstem CEO, Richard Garr, To Participate In Traumatic Brain Injury Panel At BIO International Convention
Apr 17, 2013 08:02AM Neuralstem Receives FDA Approval To Commence Phase II Stem Cell Trial In Amytrophic Lateral Sclerosis
Apr 5, 2013 09:15AM Neuralstem Receives Notice Of Allowance Of Patent Covering Use Of Stem Cells To Treat Amyotrophic Lateral Sclerosis
Mar 25, 2013 09:15AM Neuralstem Secures $8 Million In Debt Financing From Hercules